Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative.
Cardiovascular disease is the leading cause of mortality in women yet studies have suggested it is often under-recognized. Of particular concern is the apparent suboptimal treatment of women in comparison to men, with less revascularization and use of evidence-based medications. The Women in Innovations group of cardiologists, aims to highlight these issues and change perceptions to optimize the treatment of female patients with cardiovascular disease, support future research, and encourage and guide the training of female interventional cardiologists.
Chieffo
Alaide
A
Invasive Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. chieffo.alaide@hsr.it
Hoye
Angela
A
Mauri
Fina
F
Mikhail
Ghada
G
Ammerer
Michelle
M
Grines
Cindy
C
Grinfeld
Liliana
L
Madan
Mina
M
Presbitero
Patrizia
P
Skelding
Kimberly A
KA
Weiner
Bonnie H
BH
Mehran
Roxana
R
D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000628:therapy; D032921:Consensus; D001026:Coronary Artery Bypass / Q000706:statistics & numerical data; D004059:Diffusion of Innovation; D005260:Female; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006801:Humans; D008297:Male; D009204:Myocardial Revascularization / Q000706:statistics & numerical data; D012737:Sex Factors; D014930:Women
D012739:Gonadal Steroid Hormones